Daiichi Sankyo soars on $22bn Merck cancer drugs deal

Credit: Pixabay/CC0 Public DomainShares in Japan's Daiichi Sankyo soared on Friday after the pharma group announced a major cancer drug deal with US giant Merck worth up to $22 billion.Merck will

Updated on: March 08,2024

Daiichi Sankyo soars on $22bn Merck cancer drugs deal

Credit: Pixabay/CC0 Public DomainShares in Japan's Daiichi Sankyo soared on Friday after the pharma group announced a major cancer drug deal with US giant Merck worth up to $22 billion.Merck will

Updated on:March 08,2024

Study finds younger kidney cancer survivors at significant risk for heart problems

byVirginia Commonwealth UniversityCredit: Pixabay/CC0 Public DomainNew research out of VCU Massey Cancer Center indicates that many adolescent and young adult kidney cancer survivors are at a si

Updated on: January 23,2024

Study finds younger kidney cancer survivors at significant risk for heart problems

byVirginia Commonwealth UniversityCredit: Pixabay/CC0 Public DomainNew research out of VCU Massey Cancer Center indicates that many adolescent and young adult kidney cancer survivors are at a si

Updated on:January 23,2024

Researchers identify compound to prevent breast cancer cells from activating in brain

by Houston MethodistImages show tumor cells in a mouse brain at different days. Tumor cells are indicated as green dash lines. The blood vessels become leaky after day 6. In the upper panel, tumo

Updated on: June 19,2024

Researchers identify compound to prevent breast cancer cells from activating in brain

by Houston MethodistImages show tumor cells in a mouse brain at different days. Tumor cells are indicated as green dash lines. The blood vessels become leaky after day 6. In the upper panel, tumo

Updated on:June 19,2024

How the scars of demolished brain tumors seed relapse

byLudwig Cancer ResearchGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.08.012A Ludwig Cancer Research study has discovered that recurrent tumors of the aggre

Updated on: September 30,2024

How the scars of demolished brain tumors seed relapse

byLudwig Cancer ResearchGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.08.012A Ludwig Cancer Research study has discovered that recurrent tumors of the aggre

Updated on:September 30,2024

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b

Updated on: January 30,2024

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b

Updated on:January 30,2024

Study shows promising results for immunotherapy targeting skin cancer

by King's College LondonCSPG4 expression in malignant melanoma and normal tissues.aCSPG4 mRNA expression, derived from RNAseq data, across cell lines of different cancer cell type

Updated on: February 20,2024

Study shows promising results for immunotherapy targeting skin cancer

by King's College LondonCSPG4 expression in malignant melanoma and normal tissues.aCSPG4 mRNA expression, derived from RNAseq data, across cell lines of different cancer cell type

Updated on:February 20,2024

Researchers show how AI can be used to more quickly and accurately diagnose breast cancer

by University of Southern CaliforniaThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 b

Updated on: June 04,2024

Researchers show how AI can be used to more quickly and accurately diagnose breast cancer

by University of Southern CaliforniaThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 b

Updated on:June 04,2024

Software improves the ability to pinpoint specific genetic mutations that drive cancer

by Colin Poitras,Yale UniversityCredit: Unsplash/CC0 Public DomainA new open-source software package calledcancereffectsizeRdeveloped by the Townsend Lab greatly improves the ability

Updated on: January 03,2024

Software improves the ability to pinpoint specific genetic mutations that drive cancer

by Colin Poitras,Yale UniversityCredit: Unsplash/CC0 Public DomainA new open-source software package calledcancereffectsizeRdeveloped by the Townsend Lab greatly improves the ability

Updated on:January 03,2024

Scientists create powerful, most-accurate tools to research deadliest blood cancer, study says

byThe Mount Sinai HospitalCredit: CC0 Public DomainTisch Cancer Center scientists have developed unique models of the deadliest blood cancer, acute myeloid leukemia (AML), creating a transformat

Updated on: January 22,2024

Scientists create powerful, most-accurate tools to research deadliest blood cancer, study says

byThe Mount Sinai HospitalCredit: CC0 Public DomainTisch Cancer Center scientists have developed unique models of the deadliest blood cancer, acute myeloid leukemia (AML), creating a transformat

Updated on:January 22,2024

Lethal brain tumour shields itself from immune attack

by Hayley Jarvis,Brunel UniversityGBM cells can be highly invasive in the brain, or fast growing while being localised. Credit: Dr SK Singh, Gottingen Medical Centre, GermanyOne of the deadliest

Updated on: March 01,2024

Lethal brain tumour shields itself from immune attack

by Hayley Jarvis,Brunel UniversityGBM cells can be highly invasive in the brain, or fast growing while being localised. Credit: Dr SK Singh, Gottingen Medical Centre, GermanyOne of the deadliest

Updated on:March 01,2024

Being a 'morning person' linked to lower risk of breast cancer

by British Medical JournalCredit: CC0 Public DomainBeing a morning person (popularly known as larks) is associated with a lower risk of developing breast cancer than being an evening person (popu

Updated on: March 21,2024

Being a 'morning person' linked to lower risk of breast cancer

by British Medical JournalCredit: CC0 Public DomainBeing a morning person (popularly known as larks) is associated with a lower risk of developing breast cancer than being an evening person (popu

Updated on:March 21,2024

miR-10b inhibition: A strategy for treating metastatic breast cancer

by Impact Journals LLCmiR-10b inhibition by MN-anti-miR10b decreases Aldefluor accumulation and impairs spheroid formation. (A) Fluorescence microscopy of representative MDA-MB-231 cells after incubat

Updated on: September 07,2024

miR-10b inhibition: A strategy for treating metastatic breast cancer

by Impact Journals LLCmiR-10b inhibition by MN-anti-miR10b decreases Aldefluor accumulation and impairs spheroid formation. (A) Fluorescence microscopy of representative MDA-MB-231 cells after incubat

Updated on:September 07,2024